Lipidomics Screening of Anti-inflammatory Drugs and Drug Candidates in Vitro - Part A
Lipidomics Screening of Anti-inflammatory Drugs and Drug Candidates in Vitro - Part A
Active, not recruiting · NCT02095288 · Registry updated 2026-01-23Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Lipidomics Screening of Anti-inflammatory Drugs and Drug Candidates in Vitro - Part A | Healthy | Active, not recruiting | Not stated | 2026-01-23 | NCT02095288 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Eli Lilly and Company | 370 |
| University of Pennsylvania | 502 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| The Clinical Translational Research Center (CTRC) at the Hospital of the University of Pennsylvania | Philadelphia | United States | 1 |